-

08:49:19 AM

Latest IQV Stock Market News

IQV - IQVIA Holdings Inc

09/13/21 4:15 PM

NYSE, Nasdaq : IQV, NRXP

covid-19

IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment

IQVIA™, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a transformative collaboration with NRx Pharmaceuticals. New medicines with new mechanisms of action are urgently needed, "said Robert Besthof, chief commercial officer and head of Operations of NRx.

RHEA-AI

positive

09/08/21 8:00 AM

NYSE : IQV

clinical trial

IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data

IQVIA™ announces its strategic collaboration with HealthCore, Inc., a leading real world research organization in the United States, to advance real world evidence studies with increased quality and efficiency. RWE studies incorporate innovative scientific methods with dynamic data from sources such as electronic medical records, pharmacy and medical...

RHEA-AI

positive

09/02/21 4:15 PM

NYSE : IQV

conferences

IQVIA CFO, Ron Bruehlman, to Speak at the Baird 2021 Global Healthcare Conference on September 14, 2021

IQVIA Holdings Inc., announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the Baird 2021 Global Healthcare Conference on Tuesday, September 14, 2021 at 12:15 p.m. EDT. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at...

RHEA-AI

neutral

09/01/21 8:00 AM

NYSE : IQV

IQVIA Launches New A.I.-Powered MI Contact Center For Life Sciences

IQVIA™, a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced it has added new AI-powered technologies to enhance its existing Medical Information Contact Center services. Life science companies use IQVIA’ s MI Contact Center services to share information about new...

RHEA-AI

neutral

07/27/21 7:00 AM

NYSE : IQV

IQVIA Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2021.Second-Quarter 2021 Operating ResultsRevenue for the

RHEA-AI

neutral

07/22/21 8:00 AM

NYSE : IQV

Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute

Digital health tools are increasingly having a positive impact on health outcomes. Some are becoming integral parts of mainstream medicine, according to findings released today by the IQVIA Institute for Human Data Science in a new report, Digital Health Trends 2021: Innovation, Evidence,

RHEA-AI

positive

07/13/21 4:15 PM

NYSE : IQV

IQVIA to Announce Second-Quarter 2021 Results on July 27, 2021

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2021 financial results before the market opens on Tuesday, July 27, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying

RHEA-AI

neutral

06/24/21 4:15 PM

NYSE : IQV

clinical trial

IQVIA Launches the Clinical Data Analytics Suite (CDAS) to Enable Smarter, Faster Clinical Trials

IQVIA™ (NYSE: IQV) today introduced Clinical Data Analytics Suite (CDAS), a new SaaS-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single, standardized setting for easier access and use. This produces a scalable repository, that

RHEA-AI

neutral

06/14/21 8:00 AM

NYSE : IQV

Q² Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK

Q 2 Solutions, a leading global clinical trial laboratory services organization and a wholly owned subsidiary of IQVIA, has announced the expansion of its laboratory and operational capabilities at its Alba Campus in Livingston, Scotland. This expansion of central labs, genomics, flow cytometry,

RHEA-AI

very positive

06/08/21 8:00 AM

NYSE : IQV

clinical trial

Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Patients to Accelerate Adoption of Decentralized Clinical Trials

Q 2 Solutions, a wholly-owned subsidiary of IQVIA and a leading clinical trial laboratory services organization, today announced a transformative collaboration with Tasso Inc., a pioneer in clinical-grade, at-home, patient-centered blood testing, to develop diagnostic tests used in decentralized

RHEA-AI

very positive

IQV Data:

IndustryOffices of All Other Miscellaneous Health Practitioners
Websitewww.iqvia.com
CeoAri Bousbib
Security nameIQVIA Holdings Inc
Issue typecs
SectorHealth Care and Social Assistance
Sic code8731
Employees70000
Tags
- Health Services
- Services to the Health Industry
- Health Care and Social Assistance
- Offices of All Other Miscellaneous Health Practitioners
Address4820 Emperor Blvd
StateNorth Carolina
CityDurham
Zip27703-8426
CountryUS
Phone19199982000

IQV Description:

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility - enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries.